Detailed price information for Os Therapies Incorporated (OSTX-A) from The Globe and Mail including charting and trades.
Detailed price information for Os Therapies Incorporated (OSTX-A) from The Globe and Mail including charting and trades.
(“Sintana ”) and Challenger Energy Group plc (“Challenger ”) earlier today, we have reached another milestone associated with our proposed all-share acquisition of Challenger. A Scheme Document in ...
Based on strong preclinical data on HMPL-A251 in HER2-positive tumor cell lines, the firm wants to take the therapy into clinical trials by year end.
TipRanks on MSN
Oncopeptides’ NK Cell Engager Study to be Presented at ASH
The latest update is out from Oncopeptides AB ( (SE:ONCO) ).
The study will test the antibody-drug conjugate in combination with Keytruda in patients with HER2-overexpressing metastatic non-small cell lung cancer.
Ajinomoto Co., Inc. has signed a licensing agreement with Astellas Pharma Inc. for the use of AJICAP—an antibody-drug conjugate (ADC) development and manufacturing technology—as part of its CDMO ...
InvestorsHub on MSN
Intensity Therapeutics shares plunge 30% after $4 million discounted stock offering
Shares of Intensity Therapeutics Inc. (NASDAQ:INTS) tumbled nearly 30% on Friday after the late-stage biotech firm announced ...
NetTargets employs an AI system that combines multi-omics data with neural network modelling for drug discovery.
4d
Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target
Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and ...
The U.S. Food and Drug Administration (FDA) has granted fast track designation to the antibody-drug conjugate JSKN003 for the ...
Agreement expands Piramal’s payload-linker platform and bioconjugate abilities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback